{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:54:46Z","timestamp":1794048886949,"version":"4.8.0"},"reference-count":35,"publisher":"American Association for Cancer Research (AACR)","issue":"7","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Lymphangioleiomyomatosis (LAM) is a progressive cystic lung disease affecting some women with tuberous sclerosis complex (TSC). Sporadic LAM can develop in women without TSC, owing to somatic mutations in the TSC2 gene. Accumulating evidence supports the view of LAM as a low-grade, destructive, metastasizing neoplasm. The mechanisms underlying the metastatic capability of LAM cells remain poorly understood. The observed behavior of LAM cells with respect to their infiltrative growth pattern, metastatic potential, and altered cell differentiation bears similarity to cells undergoing epithelial\u2013mesenchymal transition. Here, we report increased levels of active Src kinase in LAM lungs and in TSC2\u2212\/\u2212 cells, caused by a reduction of autophagy. Furthermore, increased Src kinase activation promoted migration, invasion, and inhibition of E-cadherin expression in TSC2\u2212\/\u2212 cells by upregulating the transcription factor Snail. Notably, Src kinase inhibitors reduced migration and invasion properties of TSC2\u2212\/\u2212 cells and attenuated lung colonization of intravenously injected TSC2\u2212\/\u2212 cells in vivo to a greater extent than control TSC2+\/+ cells. Our results reveal mechanistic basis for the pathogenicity of LAM cells and they rationalize Src kinase as a novel therapeutic target for treatment of LAM and TSC. Cancer Res; 74(7); 1996\u20132005. \u00a92014 AACR.<\/jats:p>","DOI":"10.1158\/0008-5472.can-13-1256","type":"journal-article","created":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:38:53Z","timestamp":1396312733000},"page":"1996-2005","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Src Kinase Is a Novel Therapeutic Target in Lymphangioleiomyomatosis"],"prefix":"10.1158","volume":"74","author":[{"given":"Alexey","family":"Tyryshkin","sequence":"first","affiliation":[{"name":"Authors' Affiliation: Department of Medicine, Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhisek","family":"Bhattacharya","sequence":"additional","affiliation":[{"name":"Authors' Affiliation: Department of Medicine, Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. Tony","family":"Eissa","sequence":"additional","affiliation":[{"name":"Authors' Affiliation: Department of Medicine, Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2014,3,31]]},"reference":[{"key":"2022061704595795900_bib1","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1357-4310(98)01245-3","article-title":"The genetic basis of tuberous sclerosis","volume":"4","author":"Young","year":"1998","journal-title":"Mol Med Today"},{"key":"2022061704595795900_bib2","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1073\/pnas.97.11.6085","article-title":"Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis","volume":"97","author":"Carsillo","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061704595795900_bib3","doi-asserted-by":"crossref","first-page":"591","DOI":"10.4065\/75.6.591","article-title":"High frequency of pulmonary lymphangioleiomyomatosis in women with tuberous sclerosis complex","volume":"75","author":"Costello","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"2022061704595795900_bib4","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1164\/ajrccm.164.4.2011025","article-title":"Mutational and radiographic analysis of pulmonary disease consistent with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis","volume":"164","author":"Franz","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"2022061704595795900_bib5","doi-asserted-by":"crossref","first-page":"14071","DOI":"10.1074\/jbc.R109.094003","article-title":"Mammalian target of rapamycin (mTOR): conducting the cellular signaling symphony","volume":"285","author":"Foster","year":"2010","journal-title":"J Biol Chem"},{"key":"2022061704595795900_bib6","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1165\/rcmb.2005-0300OC","article-title":"Abnormal smooth muscle cell growth in lymphangioleiomyomatosis (LAM): role for tumor suppressor TSC2","volume":"34","author":"Goncharova","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2022061704595795900_bib7","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/gcc.10256","article-title":"Multiple roles of the tuberous sclerosis complex genes","volume":"38","author":"Yeung","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"2022061704595795900_bib8","doi-asserted-by":"crossref","first-page":"12455","DOI":"10.1073\/pnas.1104361108","article-title":"Tumorigenesis in tuberous sclerosis complex is autophagy and p62\/sequestosome 1 (SQSTM1)-dependent","volume":"108","author":"Parkhitko","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022061704595795900_bib9","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"N Engl J Med"},{"key":"2022061704595795900_bib10","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","article-title":"Efficacy and safety of sirolimus in lymphangioleiomyomatosis","volume":"364","author":"McCormack","year":"2011","journal-title":"N Engl J Med"},{"key":"2022061704595795900_bib11","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1172\/JCI58709","article-title":"Lymphangioleiomyomatosis-a wolf in sheep's clothing","volume":"122","author":"Henske","year":"2012","journal-title":"J Clin Invest"},{"key":"2022061704595795900_bib12","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1164\/rccm.201205-0848OE","article-title":"Lymphangioleiomyomatosis: calling it what it is: a low-grade, destructive, metastasizing neoplasm","volume":"186","author":"McCormack","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2022061704595795900_bib13","doi-asserted-by":"crossref","first-page":"7462","DOI":"10.1073\/pnas.0407971101","article-title":"Molecular and genetic analysis of disseminated neoplastic cells in lymphangioleiomyomatosis","volume":"101","author":"Crooks","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022061704595795900_bib14","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.2353\/ajpath.2010.090233","article-title":"Tuberin regulates E-cadherin localization. Implications in epithelial\u2013mesenchymal transition","volume":"177","author":"Barnes","year":"2010","journal-title":"Am J Pathol"},{"key":"2022061704595795900_bib15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ccr.2004.09.001","article-title":"c-Src and cooperating partners in human cancer","volume":"6","author":"Ishizawar","year":"2004","journal-title":"Cancer Cell"},{"key":"2022061704595795900_bib16","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/nrm1490","article-title":"Integrin signalling during tumour progression","volume":"5","author":"Guo","year":"2004","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2022061704595795900_bib17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/ncb2386","article-title":"Autophagic targeting of Src promotes cancer cell survival following reduced FAK signalling","volume":"14","author":"Sandilands","year":"2011","journal-title":"Nat Cell Biol"},{"key":"2022061704595795900_bib18","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/annonc\/mdn048","article-title":"Src as a potential therapeutic target in non\u2013small cell lung cancer","volume":"19","author":"Giaccone","year":"2008","journal-title":"Ann Oncol"},{"key":"2022061704595795900_bib19","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1165\/ajrcmb.21.3.3693","article-title":"Markers of cell proliferation and expression of melanosomal antigen in lymphangioleiomyomatosis","volume":"21","author":"Matsumoto","year":"1999","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2022061704595795900_bib20","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.cell.2007.10.035","article-title":"Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice","volume":"131","author":"Komatsu","year":"2007","journal-title":"Cell"},{"key":"2022061704595795900_bib21","first-page":"205","article-title":"Analysis of mutant forms of the c-src gene product containing a phenylalanine substitution for tyrosine 416","volume":"5","author":"Ferracini","year":"1990","journal-title":"Oncogene Res"},{"key":"2022061704595795900_bib22","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1124\/mol.109.057042","article-title":"Signal transducer and activator of transcription 3 is required for abnormal proliferation and survival of TSC2-deficient cells: relevance to pulmonary lymphangioleiomyomatosis","volume":"76","author":"Goncharova","year":"2009","journal-title":"Mol Pharmacol"},{"key":"2022061704595795900_bib23","doi-asserted-by":"crossref","first-page":"15653","DOI":"10.1073\/pnas.95.26.15653","article-title":"Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2","volume":"95","author":"Soucek","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061704595795900_bib24","first-page":"1680","article-title":"Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src","volume":"14","author":"Schaller","year":"1994","journal-title":"Mol Cell Biol"},{"key":"2022061704595795900_bib25","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/372786a0","article-title":"Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase","volume":"372","author":"Schlaepfer","year":"1994","journal-title":"Nature"},{"key":"2022061704595795900_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1513\/pats.200909-104JS","article-title":"Henske EP mammalian target of rapamycin signaling and autophagy. Roles in lymphangioleiomyomatosis therapy","volume":"7","author":"Yu","year":"2010","journal-title":"Proc Am Thorac Soc"},{"key":"2022061704595795900_bib27","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ctrv.2010.02.015","article-title":"Dasatinib: a potent SRC inhibitor in clinical development for the treatment of solid tumors","volume":"36","author":"Araujo","year":"2010","journal-title":"Cancer Treat Rev"},{"key":"2022061704595795900_bib28","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.clbc.2011.03.021","article-title":"Phase II trial of saracatinib (AZD0530), an oral SRC-inhibitor for the treatment of patients with hormone receptor-negative metastatic breast cancer","volume":"11","author":"Gucalp","year":"2011","journal-title":"Clin Breast Cancer"},{"key":"2022061704595795900_bib29","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0046-8177(97)90061-7","article-title":"Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM)","volume":"28","author":"Hayashi","year":"1997","journal-title":"Hum Pathol"},{"key":"2022061704595795900_bib30","doi-asserted-by":"crossref","first-page":"267","DOI":"10.5858\/2000-124-0267-RFAOMM","article-title":"Role for activation of matrix metalloproteinases in the pathogenesis of pulmonary lymphangioleiomyomatosis","volume":"124","author":"Matsui","year":"2000","journal-title":"Arch Pathol Lab Med"},{"key":"2022061704595795900_bib31","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1165\/rcmb.2009-0050OC","article-title":"Rapamycin-insensitive up-regulation of MMP2 and other genes in tuberous sclerosis complex 2-deficient lymphangioleiomyomatosis-like cells","volume":"42","author":"Lee","year":"2010","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2022061704595795900_bib32","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1021\/bi8020789","article-title":"PRL1 promotes cell migration and invasion by increasing MMP2 and MMP9 expression through Src and Erk1\/2 pathways","volume":"48","author":"Luo","year":"2009","journal-title":"Biochemistry"},{"key":"2022061704595795900_bib33","doi-asserted-by":"crossref","first-page":"30958","DOI":"10.1074\/jbc.M202678200","article-title":"Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation: a role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM)","volume":"277","author":"Goncharova","year":"2002","journal-title":"J Biol Chem"},{"key":"2022061704595795900_bib34","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1056\/NEJMc072500","article-title":"Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosis","volume":"358","author":"Davies","year":"2008","journal-title":"N Engl J Med"},{"key":"2022061704595795900_bib35","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ana.20784","article-title":"Rapamycin causes regression of astrocytomas in tuberous sclerosis complex","volume":"59","author":"Franz","year":"2006","journal-title":"Ann Neurol"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/74\/7\/1996\/2716276\/1996.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/74\/7\/1996\/2716276\/1996.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T11:16:49Z","timestamp":1655464609000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/74\/7\/1996\/599398\/Src-Kinase-Is-a-Novel-Therapeutic-Target-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,31]]},"references-count":35,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2014,3,31]]},"published-print":{"date-parts":[[2014,4,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-13-1256","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6505995.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22402134","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6505995","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22402134.v1","asserted-by":"object"}],"has-review":[{"id-type":"doi","id":"10.3410\/f.718335670.793501188","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,31]]}}}